Correlation of abnormal response of left ventricular ejection fraction after exercise and left ventricular cavity-to-myocardium count ratio of technetium-99m-tetrofosmin single photon emission computed tomography in patients with coronary artery disease: A preliminary report

Japanese Heart Journal

Volumn 43, Issue 5, 2002, Pages 505-514

  Ding, Hueisch J ^a   Lin, Ching C ^b   Wang, Jhi J ^b   Ho, Shung T ^c   Kao, Albert ^d  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cavity to myocardium count ratio; Left ventricular ejection fraction; Single photon emission computed tomography; Technetium 99m tetrofosmin

Indexed keywords

TETROFOSMIN TC 99M; DIAGNOSTIC AGENT; ORGANOPHOSPHORUS COMPOUND; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2 BIS(BIS(2 ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; EXERCISE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE PERFUSION; HEART VENTRICULOGRAPHY; HUMAN; MALE; PRIORITY JOURNAL; REST; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; EXERCISE TEST; HEART; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HEART VENTRICLE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; SCINTISCANNING;

ADULT; AGED; CORONARY DISEASE; EXERCISE TEST; FEMALE; HEART; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; PROGNOSIS; RADIOPHARMACEUTICALS; STROKE VOLUME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR FUNCTION, LEFT;

EID: 0036716034     PISSN: 00214868     EISSN: 1348673X     Source Type: Journal    
DOI: 10.1536/jhj.43.505     Document Type: Article

References (13)

1. Sporn V, Perez Balino N, Holman BL, et al. Simultaneous measurement of ventricular function and myocardial perfusion using the technetium-99m isonitriles. Clin Nucl Med 1988; 13: 77-81.
2. Bassevich R, Zafrir N, Sulkes J, Lubin E. Dipyridamole first-pass radionuclide ventriculography: prediction of future cardiac events. Am J Cardiol 1994; 74: 1229-32.
3. Baillet GY, Mena IG, Kuperus JH, et al. Simultaneous technetium-99m-MIBI angiography and myocardial perfusion imaging. J Nucl Med 1989; 30: 38-44.
4. Bisi G, Sciagra R, Bull U, et al. Assessment of ventricular function with first-pass radionuclide angiography using technetium-99m-hexakis-2-methoxyisobutyl: a European multicentre study. Eur J Nucl Med 1991; 18: 178-83.
5. Sciaga R, Bisi G, Santoro GM, et al. Evaluation of coronary artery disease extent and severity using 99mTcsestamibi first-pass and perfusion imaging in combination with dipyridamole infusion. J Nucl Med 1994; 35: 1254-61.
6. Sciagra R, Bisi G, Buonamici P, et al. Left ventricular cavity-to-myocardium count ratio in technetium-99msestamibi SPECT in the detection of resting left ventricular dysfunction. J Nucl Med 1997; 38: 766-70.
7. Roberti RR, Van Tosh A, Baruchin MA, et al. Left ventricular cavity-to-myocardial count ratio: a new parameter for detecting resting left ventricular dysfunction directly from tomographic thallium perfusion scintigraphy. J Nucl Med 1994; 34: 193-8.
8. Piwnica-Worms D, Holman LB. Noncardiac application of hexakis (alkyl-isonitrile) technetium-99m complexes [Editorial]. J Nucl Med 1990; 31: 1161.
9. Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyiso-butylisonitrile) technetium (I) in cultured mouse fibroblasts. J Nucl Med 1990; 31: 1646-53.
10. Higley B, Smith FW, Smith T, et al. Technetium-99m-1,2-bis(bis(2-ethoxyethyl)phosphino) ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med 1993; 34: 30-8.
11. Kelly JD, Forster AM, Higley B, et al. Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging. J Nucl Med 1993; 34: 222-7.
12. Flamen P, Bossuyt A, Franken PR. Technetium-99m-tetrofosmin in dipyridamole-stress myocardial SPECT imaging: intraindividual comparison with technetium-99m-sestamibi. J Nucl Med 1995; 36: 2009-15.
13. Wackers FJ, Berman DS, Maddahi J, et al. Technetium-99m-hexakis-2-methoxyisobutylisonitrile: human biodistribution, dosimetry, safety and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 1989; 30: 301-11.